Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of LY01015 vs Opdivo with fluorouracil and cisplatin in advanced or metastatic esophageal squamous cell carcinoma
CTR20232393Phase 3Active
- Sponsor
- Boan Biotech
- Start
- Oct 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of nivolumab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Boan Biotech. Started Oct 2023; status: active.
02
Drugs
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on CTR20232393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232393.